3-Oxa-5,9,11-triazatridecan-13-oic acid,7-hydroxy-2,2,12-trimethyl-4,10-dioxo-6,9-bis(phenylmethyl)-, methylester, (6R,7R,12R)- (853904-91-3)

Identification
Name:	3-Oxa-5,9,11-triazatridecan-13-oic acid,7-hydroxy-2,2,12-trimethyl-4,10-dioxo-6,9-bis(phenylmethyl)-, methylester, (6R,7R,12R)-
CAS:	853904-91-3
Molecular Formula:	C₂₇H₃₇N₃O₆
Molecular Structure:
Properties
Safety Data

Other Product

3-Oxa-5,9,11-triazatridecan-13-oic acid,7-hydroxy-2,2,9-trimethyl-12-(2-methylpropyl)-4,10-dioxo-6-(phenylmethyl)-, methyl ester, (6R,7R,12R)-
3-Oxa-5,9,11-triazatridecan-13-oic acid,7-hydroxy-2,2-dimethyl-4,10-dioxo-6,9,12-tris(phenylmethyl)-, methylester, (6R,7R,12R)-
2-Oxa-5,8,14-triazapentadecan-15-oic acid, 12-hydroxy-10-[(3-methoxyphenyl)methyl]-7-(1-methylethyl)-6,9-dioxo-13-(phenylmethyl)-, 1,1-dimethylethyl ester, [7S-(7R*,10S*,12R*,13R*)]-
2-Oxa-5,8,14-triazapentadecan-15-oic acid, 12-hydroxy-10-((4-hydroxyphenyl)methyl)-7-(1-methylethyl)-6,9-dioxo-13-(phenylmethyl)-, 1,1-dimethylethyl ester, (7S-(7R*,10S*,12R*,13R*))-
2-Oxa-5,8,14-triazapentadecan-15-oic acid, 12-hydroxy-10-[(2-methoxyphenyl)methyl]-7-(1-methylethyl)-6,9-dioxo-13-(phenylmethyl)-, 1,1-dimethylethyl ester, [7S-(7R*,10S*,12R*,13R*)]-
2-Oxa-5,8,14-triazapentadecan-15-oic acid, 12-hydroxy-7-(1-methylethyl)-6,9-dioxo-13-(phenylmethyl)-10-((3,4,5-trimethoxyphenyl)methyl)-, 1,1-dimethylethyl ester, (7S-(7R*,10S*,12R*,13R*))-
2-Oxa-5,8,14-triazapentadecan-15-oic acid, 10-[(3,4-dimethoxyphenyl)methyl]-12-hydroxy-7-(1-methylethyl)-6,9-dioxo-13-(phenylmethyl)-, 1,1-dimethylethyl ester, [7S-(7R*,10S*,12R*,13R*)]-
2-Oxa-4,7,12-triazatridecan-13-oicacid,1-[2-(dimethylamino)-4-thiazolyl]-9-hydroxy-5-(1-methylethyl)-3,6-dioxo-8,11-bis(phenylmethyl)-,5-thiazolylmethyl ester, [3S-(3R*,6R*,7R*,9R*)]- (9CI)
2-Oxa-4,7,11-triazatridecan-13-oic acid,5-(2-methylpropyl)-3,6,9,10-tetraoxo-1-phenyl-8,12-bis(phenylmethyl)-,(5S,8S,12R)-
12-Oxa-2,5,9,10-tetraazatetradecanoicacid,7-hydroxy-9-[(4-methoxyphenyl)methyl]-13,13-dimethyl-3-(1-methylethyl)-4,11-dioxo-6-(phenylmethyl)-,2-pyridinylmethyl ester, [3S-(3R*,6R*,7R*)]- (9CI)
2-Oxa-4,9,12-triazatridecan-13-oicacid,6-hydroxy-11-(1-methylethyl)-3,10-dioxo-5,8-bis(phenylmethyl)-1-(5-thiazolyl)-,1-[[2-(1-methylethyl)-4-thiazolyl]methyl]hydrazide, monohydrochloride,[5S-(5R*,6R*,8R*,11R*)]- (9CI)
2-Oxa-5,8,14-triazapentadecan-15-oic acid, 12-hydroxy-7-(1-methylethyl)-6,9-dioxo-10,13-bis(phenylmethyl)-, 1,1-dimethylethyl ester, (7S-(7R*,10S*,12R*,13R*))-
12-Oxa-2,3,7,10-tetraazatridecanoicacid,5-hydroxy-3-[(4-methoxyphenyl)methyl]-9-(1-methylethyl)-8,11-dioxo-6-(phenylmethyl)-13-(2-pyridinyl)-,3-pyridinylmethyl ester, [5S-(5R*,6R*,9R*)]- (9CI)
2-Oxa-4,7,11-triazatridecan-13-oic acid,5-(2-methylpropyl)-3,6,9,10-tetraoxo-1-phenyl-8,12-bis(phenylmethyl)-,methyl ester, (5S,8S,12R)-
12-Oxa-2,3,7,10-tetraazatridecanoicacid,5-hydroxy-9-(1-methylethyl)-8,11-dioxo-3,6-bis(phenylmethyl)-13-(2-pyridinyl)-,3-pyridinylmethyl ester, [5S-(5R*,6R*,9R*)]- (9CI)
1/C12H9NO/c14-9-11-3-1-2-4-12(11)10-5-7-13-8-6-10/h1-9
2-Oxa-4,7,12-triazatridecan-13-oicacid,9-hydroxy-5-(1-methylethyl)-1-[2-(1-methylethyl)-4-thiazolyl]-3,6-dioxo-8-(phenylmethyl)-11-(5-thiazolylmethyl)-,5-thiazolylmethyl ester, [5S-(5R*,8R*,9R*,11R*)]- (9CI)
2-Oxa-5,8,11-triazatridecan-13-oic acid,5-(carboxymethyl)-8,11-bis(2-methoxy-2-oxoethyl)-3-oxo-, 13-methylester, potassium salt
2-Oxa-5,8,11-triazatridecan-13-oic acid,5,8-bis(carboxymethyl)-11-(2-methoxy-2-oxoethyl)-3-oxo-
11-Oxa-2,5,9-triazatridecanoic acid,3-(1,1-dimethylethyl)-7-hydroxy-12,12-dimethyl-9-(2-methylpropyl)-4,10-dioxo-6-(phenylmethyl)-, phenylmethyl ester, (3S,6S,7R)-